EW News and Press, Edwards Lifesciences Corporation From 03/23/22

Following a rally that took the major averages to their highest levels since mid-February, Wall Street took a breather on Wednesday, with stocks posting modest declines on the session. The S&P 500 retreated about 1.2%. Medical device companies were among the stocks that saw pullbacks duri...

Hurt by the underperformance of several medical device makers on Wednesday, the S&P 500 Healthcare Index has lagged all but one sector in the benchmark index. Notable decliners include, ResMed (RMD -6.8%), Edwards Lifesciences (EW -4.2%), Boston Scientific (BSX -3.7%), and Stryker Corpora...

Wedgewood Partners’ 13F portfolio value increased from ~$709M to ~$753M this quarter. They increased Meta Platforms, Visa, Taiwan Semi, and Booking Holdings while reducing Edward Lifesciences, Motorola Solutions, and Keysight Technologies. Their top five positions are at 38...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

TAVR revenue is forecasted to grow at an average growth rate of 14.70% until 2026 supported by the aging population. We believe Edwards is benefitting heavily from economies of scale as the average SG&A as a percentage of revenue growth rate in the past decade is -3.01%. Despi...

FHLC is a well-diversified healthcare ETF concentrated on large caps. FHLC generated strong return, and closely replicated returns of S&P 500. FHLC has strong price multiples and financial growth, at par with peers. For further details see: FHLC: Well Diversified, St...

Medtech companies are being negatively impacted by the rise in energy and commodity costs caused by the ongoing conflict between Ukraine and Russia, Hammerstone Markets said. Hammerstone noted the rise in those costs could lead to fewer elective procedures. One of the companies that Hammersto...

IHI is one of the rare healthcare ETF to outperform S&P 500. IHI’s significant holdings has generated considerable price growth. Healthcare equipment and Medical Devices sector has stood out during the pandemic crisis, and is expected to grow further. For further ...

The decline from September 2021 in Medical Device stocks was healthy. Similar price structures provide confidence in coming upside. Boston Scientific is a chart that we are much more enthused about. For further details see: Riding The Stock Waves: Update On The Medical D...

Updating its Tactical U.S. Equity Themes, UBS introduced a new theme of Selloff Opporutunities. The screen "highlights a list of companies that look attractive following recent market volatility." "We believe some stocks have been unfairly punished in the sell-off," UBS' theme team wrote in a...